JPEC
Friday, September 2, 2016
BJ Towe

The Pappajohn Entrepreneurial Center's Venture School helps bring academic discoveries to market, including that of Immortagen, whose mission is to move cancer treatment from a one-size-fits-all approach to truly personalized care based on a tumor's molecular composition. Read more in this Des Moines Register article.

Tags: